IL6 and COVID-19: Furthermore, imbalanced and inappropriate inflammatory response, which is defined by low levels of type I and III IFNs contrasted to elevated chemokines and high expression of IL-6, drives the development of severe COVID-19 (Blanco-Melo et al., 2020).